https://today.ucsd.edu/story/glp-1-drugs-linked-to-dramatically-lower-death-rates-in-colon-cancer-patients Skip to main content Menu * UC San Diego UC San Diego - Today Subscribe Magnifying glass icon * Research * People * Campus & Community * Arts & Culture * Voices Research Alerts More Research Alerts GLP-1 Drugs Linked to Dramatically Lower Death Rates in Colon Cancer Patients Colon cancer patients taking GLP-1 medications were less than half as likely to die within five years compared to those who weren't on the drugs (15.5% vs. 37.1%) Story by: * Lizelda Lopez - llopez2@ucsd.edu Published Date November 11, 2025 Story by: * Lizelda Lopez - llopez2@ucsd.edu Topics covered: * Colon Cancer * GLP-1 Medication Share This: * * * * * Article Content A new University of California San Diego study offers compelling evidence that GLP-1 receptor agonists -- the class of drugs behind Ozempic, Wegovy and Mounjaro, for example -- may do more than regulate blood sugar and weight. In an analysis of more than 6,800 colon cancer patients across all University of California Health sites, researchers found that those taking glucagon-like peptide-1 (GLP-1) medications were less than half as likely to die within five years compared to those who weren't on the drugs (15.5% vs. 37.1%). The study, led by Raphael Cuomo, Ph.D., associate professor in the Department of Anesthesiology at UC San Diego School of Medicine and member of UC San Diego Moores Cancer Center, used real-world clinical data from the University of California Health Data Warehouse to assess outcomes across the state's academic medical centers. After adjusting for age, body mass index (BMI), disease severity and other health factors, GLP-1 users still showed significantly lower odds of death, suggesting a strong and independent protective effect. The survival benefit appeared most pronounced in patients with very high BMI (over 35), hinting that GLP-1 drugs may help counteract the inflammatory and metabolic conditions that worsen colon cancer prognosis. Researchers believe several biological mechanisms could explain the link. Beyond regulating blood sugar, GLP-1 receptor agonists reduce systemic inflammation, improve insulin sensitivity and promote weight loss -- all factors that can dampen tumor-promoting pathways. Laboratory studies also suggest that GLP-1 drugs may directly prevent cancer cell growth, trigger cancer cell death and reshape the tumor microenvironment. However, the study authors emphasize that more research is needed to confirm these mechanisms and determine whether the survival benefit observed in this real-world analysis represents a direct anti-cancer effect or an indirect result of improved metabolic health. Cuomo notes that while these results are observational, they underscore an urgent need for clinical trials to test whether GLP-1 drugs can improve cancer survival rates, especially for patients with obesity-related cancers. The study appeared in Cancer Investigation on Nov. 11, 2025. Topics covered: * Colon Cancer * GLP-1 Medication Share This: * * * * * You May Also Like New Rady School Report: Military Spending Remains Cornerstone of San Diego's Economy Business & Economics The Military Economic Impact Report was released in conjunction with a press conference Nov. 12 at Admiral Kidd Club in San Diego. UC San Diego Will Lead a New California Effort to Make Fusion Energy a Practical Reality Science & Environment High-powered lasers shining green and purple light Upgraded UC San Diego Facility Accelerates Efforts to Develop Materials for Fusion Reactor Walls Science & Environment PISCES lab researchers install the POSEIDON device GLP-1 Drugs Linked to Dramatically Lower Death Rates in Colon Cancer Patients Health & Behavior GLP-1 graphic UC San Diego Will Lead a New California Effort to Make Fusion Energy a Practical Reality Science & Environment High-powered lasers shining green and purple light Upgraded UC San Diego Facility Accelerates Efforts to Develop Materials for Fusion Reactor Walls Science & Environment PISCES lab researchers install the POSEIDON device GLP-1 Drugs Linked to Dramatically Lower Death Rates in Colon Cancer Patients Health & Behavior GLP-1 graphic New Rady School Report: Military Spending Remains Cornerstone of San Diego's Economy Business & Economics The Military Economic Impact Report was released in conjunction with a press conference Nov. 12 at Admiral Kidd Club in San Diego. Stay in the Know Keep up with all the latest from UC San Diego. Subscribe to the newsletter today. Email [ ] Please provide a valid email address. Subscribe Subscription Notification Close Confirmation Thank you! You have been successfully subscribed to the UC San Diego Today Newsletter. Contact Information UC San Diego Homepage 9500 Gilman Drive, La Jolla, CA 92093-0021 (858) 534-2230 Site Directory * Media Resources & Contacts * Newsletter * Emergency Status * Disability Resources * Principles of Community * Organizational Transformation * University Communications * Key Issues Follow Us on Social Media * UC San Diego Linkedin Account * UC San Diego Instagram Account * UC San Diego Twitter Account * UC San Diego Facebook Account * UC San Diego Youtube Account * UC San Diego Tiktok Account * UC San Diego Threads Account * UC San Diego Blue sky Account Divisions & Schools * Arts and Humanities * Biological Sciences * Division of Extended Studies * Division of Graduate Education and Postdoctoral Affairs * Division of Undergraduate Education * Halicioglu Data Science Institute * Jacobs School of Engineering * Physical Sciences * Rady School of Management * School of Global Policy & Strategy * School of Medicine * Scripps Institution of Oceanography * Skaggs School of Pharmacy * Social Sciences * Wertheim School of Public Health (c) 2021 Regents of the University of California. All rights reserved. Terms of Use | Accessibility | Privacy | Feedback Category navigation with Social links X icon Close * Research Right pointing chevron Research Right pointing chevron Right pointing chevron Back + The Arts + Business & Economics + Health & Behavior + Humanities + Politics & Society + Science & Environment + Technology & Engineering All Research Collapse Research navigation * People Right pointing chevron People Right pointing chevron Right pointing chevron Back + Awards & Accolades + In Memoriam + Milestones + Profiles All People Collapse People navigation * Campus & Community Right pointing chevron Campus & Community Right pointing chevron Right pointing chevron Back + At Work + Athletics + Campus News + Giving + Student Life All Campus & Community Collapse Campus & Community navigation * Arts & Culture Right pointing chevron Arts & Culture Right pointing chevron Right pointing chevron Back + Books & Culture + Events & Happenings + Visual & Performing Arts All Arts & Culture Collapse Arts & Culture navigation * Voices Right pointing chevron Voices Right pointing chevron Right pointing chevron Back + Insights & Experts + Opinion + Q&A All Voices Collapse Voices navigation * Visual Storytelling Right pointing chevron Visual Storytelling Right pointing chevron For Media: * Media Resources & Contacts Right pointing chevron Publications: * UC San Diego Today Newsletter Right pointing chevron * UC San Diego Magazine Right pointing chevron * Discoveries Magazine Right pointing chevron Follow Us: * UC San Diego Linkedin Account * UC San Diego Instagram Account * UC San Diego Twitter Account * UC San Diego Facebook Account * UC San Diego Youtube Account * UC San Diego Tiktok Account * UC San Diego Threads Account * UC San Diego Blue sky Account UC San Diego Homepage X icon Close Close X icon Search UC San Diego Today [ ] Include Department News